Who owns AVEO Pharmaceuticals?

Key details on AVEO Pharmaceuticals (Ticker: AVEO)

Who owns AVEO Pharmaceuticals?

Is AVEO a good stock to own? Find out who bought AVEO Pharmaceuticals, who sold AVEO Pharmaceuticals (AVEO) stock, and who holds a large position in AVEO Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Baupost 3.83M $5.74M March 31, 2014
Dr. Jeffrey R. Jay, M.D. 2.87M $4.27M March 31, 2014
Sarissa Capital Management 2.57M $3.83M March 31, 2014
BlackRock Institutional Trust Company, N.A. 2.51M $3.77M March 31, 2014
ALLIANCEBERNSTEIN 2.10M $26.09M March 31, 2012
Vanguard 1.53M $2.30M March 31, 2014
BlackRock Fund Advisors 1.44M $2.14M March 31, 2014
Palo Alto Investors 1.43M $2.14M March 31, 2014
MPM Asset Management 1.37M $2.51M Dec. 31, 2013
Renaissance Technologies 1.28M $1.91M March 31, 2014
D. E. Shaw & Co 1.11M $1.66M March 31, 2014
AQR Capital Management 917507 $2.29M June 30, 2013
TCW 908419 $9.46M Sept. 30, 2012
FMR 870455 $1.60M Dec. 31, 2013
Credit Suisse AG 841034 $2.10M June 30, 2013
Technical Financial Services 833762 $1.72M Sept. 30, 2013
STATE STREET CORPORATION 759446 $1.13M March 31, 2014
GRANAHAN INVESTMENT MANAGEMENT INC/MA 676451 $1.24M June 30, 2014
Deer VI & Co 675242 $1.01M March 31, 2014
NORTHERN TRUST 628839 $930681 March 31, 2014
OppenheimerFunds 598602 $7.43M March 31, 2012
Greylock XI GP Limited Partnership 584004 $1.07M June 30, 2014
Oracle Investment Management 575000 $1.18M Sept. 30, 2013
Sabby Management 573416 $860 March 31, 2014
JPMORGAN CHASE & CO 554235 $6.73M June 30, 2012
Deutsche Bank Aktiengesellschaft 550694 $1.01M Dec. 31, 2013
Wellington Management Company 549539 $1.14M Sept. 30, 2013
Royce & Associates 540000 $1.35M June 30, 2013
Baker Bros. Advisors 519833 $3.82M March 31, 2013
S.A.C. Capital Advisors 500000 $750000 March 31, 2014
BlackRock Advisors 454451 $936169 Sept. 30, 2013

Who sold AVEO Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Alyeska Investment Sept. 30, 2011 507902 $7.82M
Sectoral Asset Management June 30, 2011 1.22M $25.23M
Black Horse Capital Management June 30, 2011 474725 $9.78M
OrbiMed Advisors Dec. 31, 2010 953581 $13.94M
Brookside Capital Management, LLC* Dec. 31, 2010 883958 $12.92M